Physician profile
Faiz U Ahmad
NPI 1285876946
$46,702.04
in general payments reported to CMS, 2019-2025
13 companies · $2,472 in 2025
The $2,472 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $5,659 · 2021: $2,828 · 2022: $6,495 · 2023: $3,938 · 2024: $3,788 · 2025: $2,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Travel and Lodging: $3,107 · Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $3,107.26 |
| Food and Beverage | $591.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $28,922.62 | 2019-2025 | Cascadia Interbody System, Sonopet Iq, Core |
| Mirus, LLC | $8,750.00 | 2019-2020 | |
| Medtronic USA, INC. | $6,576.33 | 2019-2020 | |
| Alphatec Spine, INC | $1,541.93 | 2025 | Other - Miscellaneous |
| United Orthopedics LLC | $323.01 | 2025 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Globus Medical, INC. | $143.35 | 2025 | Alif |
| Kci USA, INC. | $52.84 | 2021 | |
| Medtronic, INC. | $35.21 | 2024 | Unid_pass |
| Depuy Synthes Sales INC. | $30.69 | 2025 | Fibergraft Bg Morsels |
| Becton, Dickinson and Company | $25.25 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $12.61 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiz Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.